The facial injectable market size is projected to touch over US$ 28.13 billion by 2030, growing at a CAGR of 9.7% every year, according to a 2022 study by Precedence Research, the Canada-based market Insight Company.
The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2022 to 2030. The facial injectable market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).
The traditional syringes, needle-free injectors, auto, and pen injectors have all been employed for medication administration in the treatment of medical illnesses, particularly cancer and autoimmune disorders. The market for facial injectables is divided into two categories that is high-end and sophisticated technology-based products. The facial injectables market is driven by the rising prevalence of chronic diseases, the growing usage of self-injectable devices, and the expansion of Food and Drug Administration (FDA) approvals. Furthermore, there is a steady increase in the geriatric population. Along with the elderly, the younger generation is increasingly drawn to the cosmetics sector in order to appear youthful.
The facial injectables are used to improve the physical appearance of the skin in certain areas of the face. Collagen, hyaluronic acid, and calcium hydroxylapatite are commonly used in these injectables to help restore skin suppleness. They areutilized to smooth wrinkles, plump lips, improve shallow contours, and lift depressed scars. The face injectables are currently gaining popularity around the world since they are safe, cost-effective, and require little downtime.
Download a FREE Sample Copy (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1594
Facial Injectable Market Scope
| Report Coverage | Details |
| Market Size by 2030 | USD 28.13 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.7% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Facial Injectable Market Report Highlights
- Based on the product, the botulinum toxin Type A segment dominated the global facial injectable market in 2020 with highest market share. The botulinum toxin Type A in its cosmetic version, known to patients as Botox, is a popular injection that temporarily reduces or removes facial small lines and wrinkles. The forehead creases and frown lines are the most typically treated locations.
- North America is the largest segment for facial injectable market in terms of region. North America controlled the facial injectable market and has a high level of knowledge regarding the state of healthcare and its costs.
- Asia-Pacific region is the fastest growing region in the facial injectable market. The higher awareness about aesthetic surgical procedures, the presence of key market players, and an increasing geriatric population, technological advancements, and demand for minimally invasive aesthetic procedures are some of the factors driving the growth of the facial injectable market in the Asia-Pacific region.
Facial Injectable Market Dynamics
Drivers
Surge in demand for aesthetic procedures
The increased awareness has resulted in an increase in demand for aesthetic procedures. Furthermore, as developing countries around the world improve economically, disposable income has risen dramatically. As a result, an increasing number of people are opting for various filler injections to improve their aesthetic appearance. There has also been a considerable shift in attitudes about these cosmetic treatments, reducing the stigma associated with them. As a result, the surge in demand for aesthetic procedures will drive the growth of the global facial injectable market during the forecast period.
Restraints
High cost of facial injectables
The average cost of hyaluronic acid fillers is $682 per syringe, according to American Society of Plastic Surgeons (ASPS) price data from 2018. To attain the intended results, most people will need more than one syringe. Botox, on the other hand, is sold in units and costs between $10 and $15 each unit. For example, to treat the forehead and eye area, an average dosage of 30-40 units might be employed, resulting in a total cost of $300 to $600. Thus, the high cost of facial injectables is hindering the market growth.
Read Also: Anti-aging Market Size Gain US$ 119.6 Bn By 2030
Opportunities
Surge in adoption of facial injectable
An increasing proportion of the male population is predicted to adopt facial injectable in the forecast period, which is one of the most unique and widespread trends in the worldwide market. During the forecast period, this particular trend is expected to contribute positively to the facial injectable market growth. Additionally, because males do not want a more apparent improvement of their facial characteristics, less invasive procedures such as botulinum toxin are a popular alternative. More males are predicted to use facial injectables rather than invasive cosmetic procedures as a result of this. The facial injectable growth is projected to be aided by such developments.
Challenges
Side effects of the treatments
The market for facial injectables is projected to be hampered by the negative effects associated with dermal injectables over the forecast period. The injection technique used by the healthcare provider, for example, can influence whether or not the patient has bruise and stiffness. The rapid filler injection and the use of large number of fillers have all been proven to enhance the risk of bruising. Furthermore, if the filler is injected too superficially, it can create a bluish discoloration of the skin covering the filler in some cases. As a result, the side effects of the treatments are a major challenge for the growth of the global facial injectable market during the forecast period.
Some of the prominent players in the global facial injectable market include:
- Johnson & Johnson
- Syneron Candela
- Lumenis
- Hologic
- Solta Medical
- Alma Laser
- Galderma
- Dickinson and Company
- Antares Pharma
- Novartis AG
Facial Injectable Market Segments
By Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylaptite (CaHA)
- Polymer Fillers
- Others
By Application
- Aesthetics
- Therapeutics
End User
- Hospitals
- Specialty Clinics
- Spa & Beauty Clinics
By Generation
- Gen X
- Boomer
- Millennials
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333